FALBERG KATHRYN E
Insider CIK 1206977 · MDVN Director · BMRN Director · HALO Director · JAZZ SVP and CFO, 10% owner · LIFE Director · TCDA Director · AIMT Director · AXON Director · URGN Director · TTD Director · RCUS Director · NUVB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2026-06-11 | 2026-06-12 | 16,900 | — | $0 | 16,900 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2026-06-11 | 2026-06-12 | 5,700 | — | $0 | 44,300 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2026-05-21 | 2026-05-26 | 123,397 | — | $0 | 123,397 | SEC↗ |
| TTD Trade Desk, Inc. | D To issuer | 2026-03-23 | 2026-03-25 | 212 | $59.17 | $12.5K | 508 | SEC↗ |
| TTD Trade Desk, Inc. | D To issuer | 2026-03-23 | 2026-03-25 | 296 | $59.17 | $17.5K | 212 | SEC↗ |
| TTD Trade Desk, Inc. | D To issuer | 2026-03-23 | 2026-03-25 | 212 | $59.17 | $12.5K | 0 | SEC↗ |
| TTD Trade Desk, Inc. | D To issuer | 2026-03-23 | 2026-03-25 | 1,226 | — | $0 | 720 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2026-03-05 | 2026-03-09 | 102,828 | $30.45 | $3.13M | 1,946 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2026-03-05 | 2026-03-09 | 50,000 | $30.48 | $1.52M | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 38,300 | — | $0 | 38,300 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2025-06-10 | 2025-06-12 | 13,300 | — | $0 | 68,600 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2025-05-27 | 2025-05-29 | 845 | $59.17 | $50.0K | 102,746 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2025-05-27 | 2025-05-29 | 1,183 | $59.17 | $70.0K | 103,929 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2025-05-27 | 2025-05-29 | 845 | $59.17 | $50.0K | 104,774 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2025-05-27 | 2025-05-29 | 4,901 | — | $0 | 101,901 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2025-05-21 | 2025-05-23 | 292,983 | — | $0 | 292,983 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2025-04-15 | 2025-04-17 | 90 | $63.73 | $5.7K | 97,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2024-09-03 | 2024-09-05 | 200,801 | — | $0 | 200,801 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2024-08-13 | 2024-08-15 | 150,000 | $98.17 | $14.73M | 96,910 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 24,000 | — | $0 | 24,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2024-06-06 | 2024-06-07 | 8,400 | — | $0 | 55,300 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2024-05-28 | 2024-05-30 | 573 | $87.16 | $49.9K | 246,337 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2024-05-28 | 2024-05-30 | 3,155 | — | $0 | 245,764 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2024-05-28 | 2024-05-30 | 573 | $87.16 | $49.9K | 246,910 | SEC↗ |
| TTD Trade Desk, Inc. | M Exercise deriv | 2024-03-08 | 2024-03-12 | 103,030 | — | $0 | 103,030 | SEC↗ |
| TTD Trade Desk, Inc. | C Conversion deriv | 2024-03-08 | 2024-03-12 | 103,030 | — | $0 | 0 | SEC↗ |
| TTD Trade Desk, Inc. | M Exercise deriv | 2024-03-08 | 2024-03-12 | 103,030 | — | $0 | 0 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2024-03-08 | 2024-03-12 | 95 | $82.36 | $7.8K | 242,609 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2024-03-08 | 2024-03-12 | 102,935 | $81.90 | $8.43M | 242,704 | SEC↗ |
| TTD Trade Desk, Inc. | C Conversion | 2024-03-08 | 2024-03-12 | 103,030 | $1.80 | $185.5K | 345,639 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 19,500 | — | $0 | 19,500 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2023-06-15 | 2023-06-16 | 6,800 | — | $0 | 46,900 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | G Gift | 2023-06-15 | 2023-06-16 | 50,504 | — | $0 | 40,100 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2023-05-25 | 2023-05-30 | 799 | $62.52 | $50.0K | 241,810 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2023-05-25 | 2023-05-30 | 799 | $62.52 | $50.0K | 242,609 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2023-05-25 | 2023-05-30 | 4,238 | — | $0 | 241,011 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2023-05-15 | 2023-05-17 | 366,744 | — | $0 | 366,744 | SEC↗ |
| TTD Trade Desk, Inc. | D To issuer | 2023-02-06 | 2023-02-08 | 21 | $59.83 | $1.3K | 236,752 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2022-12-05 | 2022-12-05 | 43,000 | $1.95 | $83.8K | 250,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2022-12-02 | 2022-12-05 | 47,000 | $1.98 | $93.1K | 207,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2022-12-01 | 2022-12-05 | 84,959 | $1.97 | $167.4K | 160,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | P Buy | 2022-11-30 | 2022-12-05 | 75,041 | $1.85 | $138.8K | 75,041 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 27,207 | — | $0 | 27,207 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 16,800 | — | $0 | 16,800 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2022-06-14 | 2022-06-16 | 4,100 | — | $0 | 90,604 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2022-05-26 | 2022-05-31 | 4,178 | — | $0 | 235,588 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2022-05-26 | 2022-05-31 | 267 | $59.83 | $16.0K | 236,690 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2022-05-26 | 2022-05-31 | 835 | $59.83 | $50.0K | 236,423 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2022-05-26 | 2022-05-31 | 83 | $59.83 | $5.0K | 236,773 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-05-16 | 2022-05-18 | 118,784 | — | $0 | 118,784 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2022-05-16 | 2022-06-28 | 140,713 | — | $0 | 140,713 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2021-11-19 | 2021-11-23 | 47,719 | $108.90 | $5.20M | 71,718 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2021-11-19 | 2021-11-23 | 80,563 | $108.03 | $8.70M | 119,437 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2021-11-19 | 2021-11-23 | 21,468 | $109.98 | $2.36M | 50,250 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2021-11-19 | 2021-11-23 | 250 | $110.44 | $27.6K | 50,000 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-10-29 | 2021-11-02 | 45,229 | — | $0 | 45,229 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 57,235 | — | $0 | 57,235 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2021-06-10 | 2021-06-11 | 16,403 | — | $0 | 59,163 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-06-07 | 2021-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2021-06-03 | 2021-06-07 | 14,100 | — | $0 | 14,100 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2021-06-03 | 2021-06-07 | 3,000 | — | $0 | 86,504 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2021-05-27 | 2021-06-01 | 25 | $639.65 | $16.0K | 3,134 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2021-05-27 | 2021-06-01 | 390 | — | $0 | 3,031 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2021-05-27 | 2021-06-01 | 78 | $639.65 | $49.9K | 3,109 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2021-05-27 | 2021-06-01 | 7 | $639.65 | $4.5K | 3,141 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2021-03-31 | 2021-04-02 | 20,000 | $28.35 | $567.0K | 102,106 | SEC↗ |
| NUVB Nuvation Bio Inc. | A Award deriv | 2021-02-10 | 2021-02-12 | 239,361 | — | $0 | 239,361 | SEC↗ |
| TTD Trade Desk, Inc. | M Exercise deriv | 2020-11-19 | 2020-11-23 | 20,000 | — | $0 | 10,303 | SEC↗ |
| TTD Trade Desk, Inc. | C Conversion deriv | 2020-11-19 | 2020-11-23 | 20,000 | — | $0 | 0 | SEC↗ |
| TTD Trade Desk, Inc. | M Exercise deriv | 2020-11-19 | 2020-11-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 5,670 | $811.00 | $4.60M | 11,239 | SEC↗ |
| TTD Trade Desk, Inc. | C Conversion | 2020-11-19 | 2020-11-23 | 20,000 | — | $0 | 22,641 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 232 | $806.63 | $187.1K | 22,409 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 795 | $807.84 | $642.2K | 21,614 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 13 | $820.00 | $10.7K | 3,270 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 825 | $819.06 | $675.7K | 3,283 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 4,139 | $818.15 | $3.39M | 4,108 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 1,891 | $815.00 | $1.54M | 8,247 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 10 | $814.00 | $8.1K | 10,138 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 891 | $813.04 | $724.4K | 10,148 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 200 | $811.68 | $162.3K | 11,039 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 629 | $822.00 | $517.0K | 2,641 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 2,852 | $810.19 | $2.31M | 16,909 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2020-11-19 | 2020-11-23 | 1,853 | $809.03 | $1.50M | 19,761 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 15,398 | $17.39 | $267.8K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 11,432 | $14.60 | $166.9K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 19,755 | $19.10 | $377.3K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 17,500 | $16.24 | $284.2K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer deriv | 2020-10-13 | 2020-10-14 | 7,500 | $1.71 | $12.8K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | D To issuer | 2020-10-13 | 2020-10-14 | 7,840 | $34.50 | $270.5K | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | U Tender | 2020-10-10 | 2020-10-14 | 69,894 | $34.50 | $2.41M | 0 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | U Tender | 2020-10-10 | 2020-10-14 | 65,192 | $34.50 | $2.25M | 0 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2020-06-11 | 2020-06-15 | 22,967 | — | $0 | 22,967 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2020-06-11 | 2020-06-15 | 5,670 | — | $0 | 42,760 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-06-08 | 2020-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2020-06-04 | 2020-06-08 | 14,000 | — | $0 | 14,000 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award | 2020-06-04 | 2020-06-08 | 3,000 | — | $0 | 83,504 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2020-05-27 | 2020-05-29 | 15,398 | — | $0 | 15,398 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2020-05-27 | 2020-05-29 | 7,840 | — | $0 | 73,032 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2020-05-26 | 2020-05-28 | 20 | $249.66 | $5.0K | 2,641 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2020-05-26 | 2020-05-28 | 180 | $249.66 | $44.9K | 2,557 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2020-05-26 | 2020-05-28 | 901 | — | $0 | 2,377 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2020-05-26 | 2020-05-28 | 64 | $249.66 | $16.0K | 2,621 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2019-11-11 | 2019-11-13 | 19,500 | $206.95 | $4.04M | 20,000 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2019-11-11 | 2019-11-13 | 10,286 | $207.08 | $2.13M | 1,476 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-06-13 | 2019-06-14 | 12,935 | $8.52 | $110.2K | 82,106 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-06-12 | 2019-06-13 | 10,000 | $8.49 | $84.9K | 69,171 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-06-11 | 2019-06-13 | 10,000 | $7.90 | $79.0K | 59,171 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-06-10 | 2019-06-11 | 10,000 | $8.25 | $82.5K | 49,171 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2019-06-07 | 2019-06-11 | 22,065 | $7.99 | $176.3K | 39,171 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2019-06-03 | 2019-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2019-05-31 | 2019-06-04 | 7,068 | — | $0 | 7,068 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2019-05-31 | 2019-06-04 | 1,879 | — | $0 | 37,090 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2019-05-23 | 2019-05-28 | 11,432 | — | $0 | 11,432 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2019-05-23 | 2019-05-28 | 6,442 | — | $0 | 65,192 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2019-04-30 | 2019-05-02 | 77 | $207.03 | $15.9K | 11,714 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2019-04-30 | 2019-05-02 | 48 | $207.03 | $9.9K | 11,762 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2019-04-30 | 2019-05-02 | 1,086 | — | $0 | 11,372 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2019-04-30 | 2019-05-02 | 48 | $207.03 | $9.9K | 11,637 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2019-04-30 | 2019-05-02 | 217 | $207.03 | $44.9K | 11,589 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2019-03-11 | 2019-03-13 | 40,000 | $205.47 | $8.22M | 20,000 | SEC↗ |
| TTD Trade Desk, Inc. | S Sale | 2018-11-28 | 2018-11-30 | 20,000 | $134.83 | $2.70M | 60,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | G Gift | 2018-11-01 | 2019-05-28 | 69,894 | — | $0 | 69,894 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | G Gift | 2018-11-01 | 2019-05-28 | 69,894 | — | $0 | 58,750 | SEC↗ |
| TTD Trade Desk, Inc. | G Gift | 2018-09-21 | 2018-11-30 | 500 | — | $0 | 49,786 | SEC↗ |
| TCDA Tricida, Inc. | A Award deriv | 2018-07-02 | 2018-07-02 | 13,147 | — | $0 | 13,147 | SEC↗ |
| TCDA Tricida, Inc. | P Buy | 2018-07-02 | 2018-07-02 | 31,579 | $19.00 | $600.0K | 31,579 | SEC↗ |
| TCDA Tricida, Inc. | A Award | 2018-07-02 | 2018-07-02 | 3,632 | — | $0 | 35,211 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2018-05-23 | 2018-05-24 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award | 2018-05-23 | 2018-05-24 | 3,750 | — | $0 | 128,644 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2018-05-03 | 2018-05-07 | 4,045 | — | $0 | 48,648 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2018-05-03 | 2018-05-07 | 1,638 | $49.44 | $81.0K | 50,286 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion deriv | 2018-03-19 | 2018-03-19 | 17,106 | — | $0 | 0 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | P Buy | 2018-03-19 | 2018-03-19 | 30,000 | $15.00 | $450.0K | 80,504 | SEC↗ |
| RCUS Arcus Biosciences, Inc. | C Conversion | 2018-03-19 | 2018-03-19 | 17,106 | — | $0 | 17,106 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2018-02-26 | 2018-02-26 | 30,000 | $32.00 | $960.0K | 124,894 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2017-07-20 | 2017-07-24 | 3,301 | — | $0 | 43,301 | SEC↗ |
| TTD Trade Desk, Inc. | A Award | 2017-07-20 | 2017-07-24 | 1,302 | $54.52 | $71.0K | 44,603 | SEC↗ |
| TTD Trade Desk, Inc. | P Buy | 2017-06-15 | 2017-06-16 | 20,000 | $48.06 | $961.2K | 80,000 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2017-05-25 | 2017-05-30 | 17,500 | — | $0 | 17,500 | SEC↗ |
| AXON Axovant Sciences Ltd. | A Award deriv | 2017-05-15 | 2017-05-16 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AXON Axovant Sciences Ltd. | P Buy | 2017-04-17 | 2017-04-19 | 53,937 | $18.54 | $1000.0K | 53,937 | SEC↗ |
| TTD Trade Desk, Inc. | P Buy | 2017-03-01 | 2017-03-03 | 20,000 | $43.38 | $867.6K | 60,000 | SEC↗ |
| TTD Trade Desk, Inc. | P Buy | 2016-11-15 | 2016-11-16 | 20,000 | $25.49 | $509.8K | 40,000 | SEC↗ |
| TTD Trade Desk, Inc. | P Buy | 2016-11-14 | 2016-11-16 | 20,000 | $25.92 | $518.4K | 20,000 | SEC↗ |
| TTD Trade Desk, Inc. | P Buy | 2016-11-14 | 2016-11-16 | 40,000 | $25.99 | $1.04M | 40,000 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 12,232 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 9,584 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,284 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 6,228 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | D To issuer deriv | 2016-09-28 | 2016-09-30 | 30,000 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | U Tender | 2016-09-28 | 2016-09-30 | 50,000 | — | $0 | 0 | SEC↗ |
| MDVN MEDIVATION, INC. | U Tender | 2016-09-28 | 2016-09-30 | 32,742 | — | $0 | 0 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-07-15 | 2016-07-19 | 8,230 | — | $0 | 8,230 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award deriv | 2016-07-15 | 2016-09-01 | 9,880 | — | $0 | 9,880 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-07-15 | 2016-07-19 | 3,300 | — | $0 | 3,300 | SEC↗ |
| BMRN BIOMARIN PHARMACEUTICAL IN | A Award | 2016-07-15 | 2016-09-01 | 2,640 | — | $0 | 2,640 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2016-06-22 | 2016-06-23 | 6,228 | — | $0 | 6,228 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2016-06-22 | 2016-06-23 | 2,972 | — | $0 | 32,742 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | A Award deriv | 2016-05-25 | 2016-05-27 | 19,755 | — | $0 | 19,755 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-05-24 | 2016-05-26 | 18,000 | — | $0 | 18,000 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2016-05-04 | 2016-05-06 | 20,202 | — | $0 | 358,253 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2016-01-27 | 2016-01-29 | 19,428 | — | $0 | 19,428 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2016-01-13 | 2016-01-14 | 10,000 | $10.37 | $103.7K | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise deriv | 2016-01-13 | 2016-01-14 | 10,000 | $4.94 | $49.4K | 0 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2016-01-13 | 2016-01-14 | 10,000 | $10.37 | $103.7K | 328,051 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | M Exercise | 2016-01-13 | 2016-01-14 | 10,000 | $4.94 | $49.4K | 338,051 | SEC↗ |
| AIMT Aimmune Therapeutics, Inc. | P Buy | 2015-08-11 | 2015-08-11 | 25,000 | $16.00 | $400.0K | 94,894 | SEC↗ |
| LIFE aTYR PHARMA INC | A Award deriv | 2015-07-08 | 2015-07-10 | 6,286 | — | $0 | 6,286 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2015-06-16 | 2015-06-18 | 3,142 | — | $0 | 3,142 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2015-06-16 | 2015-06-18 | 1,578 | — | $0 | 14,885 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2015-05-06 | 2015-05-07 | 13,175 | — | $0 | 318,051 | SEC↗ |
| MDVN MEDIVATION, INC. | P Buy | 2015-02-27 | 2015-03-02 | 19,400 | $117.76 | $2.28M | 22,800 | SEC↗ |
| MDVN MEDIVATION, INC. | P Buy | 2015-02-27 | 2015-03-02 | 3,400 | $116.51 | $396.1K | 3,400 | SEC↗ |
| MDVN MEDIVATION, INC. | P Buy | 2015-02-27 | 2015-03-02 | 800 | $119.11 | $95.3K | 25,000 | SEC↗ |
| MDVN MEDIVATION, INC. | P Buy | 2015-02-27 | 2015-03-02 | 1,400 | $118.37 | $165.7K | 24,200 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2014-06-27 | 2014-07-01 | 4,792 | — | $0 | 4,792 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2014-06-27 | 2014-07-01 | 2,250 | — | $0 | 13,307 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2014-05-13 | 2014-05-14 | 24,876 | — | $0 | 304,876 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2014-03-05 | 2014-03-06 | 1,538 | $157.60 | $242.4K | 133,387 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise deriv | 2014-02-26 | 2014-02-27 | 10,204 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise | 2014-02-26 | 2014-02-27 | 10,204 | $7.35 | $75.0K | 134,925 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2014-02-12 | 2014-02-14 | 2,000 | $157.00 | $314.0K | 124,721 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2014-01-08 | 2014-01-10 | 2,000 | $131.82 | $263.6K | 126,721 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2013-12-11 | 2013-12-13 | 3,000 | $120.50 | $361.5K | 128,721 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2013-11-13 | 2013-11-15 | 3,000 | $100.88 | $302.6K | 131,372 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2013-10-09 | 2013-10-11 | 3,000 | $83.10 | $249.3K | 134,372 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2013-09-11 | 2013-09-13 | 3,000 | $87.52 | $262.6K | 137,372 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | P Buy | 2013-08-14 | 2013-08-14 | 50,000 | $6.91 | $345.5K | 280,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2013-08-14 | 2013-08-14 | 3,000 | $81.02 | $243.1K | 140,372 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | P Buy | 2013-08-12 | 2013-08-14 | 50,000 | $6.72 | $336.0K | 230,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | F Tax w/h | 2013-08-09 | 2013-08-13 | 3,464 | $80.88 | $280.2K | 143,372 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2013-07-10 | 2013-07-12 | 3,000 | $72.40 | $217.2K | 146,836 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2013-06-28 | 2013-07-02 | 6,116 | — | $0 | 6,116 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2013-06-28 | 2013-07-02 | 3,557 | — | $0 | 11,057 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2013-05-16 | 2013-05-16 | 20,000 | — | $0 | 180,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise deriv | 2013-03-05 | 2013-03-05 | 44,216 | — | $0 | 10,204 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2013-03-05 | 2013-03-06 | 1,691 | — | $0 | 1,691 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2013-03-05 | 2013-03-06 | 30,309 | — | $0 | 30,309 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | M Exercise | 2013-03-05 | 2013-03-05 | 44,216 | $7.35 | $325.0K | 133,417 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2013-03-05 | 2013-03-06 | 16,000 | — | $0 | 149,417 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2013-01-31 | 2013-02-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award deriv | 2013-01-31 | 2013-02-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDVN MEDIVATION, INC. | A Award | 2013-01-31 | 2013-02-04 | 7,500 | — | $0 | 7,500 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | P Buy | 2012-11-13 | 2012-11-14 | 50,000 | $5.21 | $260.5K | 160,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2012-08-16 | 2012-08-17 | 7,000 | $47.48 | $332.4K | 88,782 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | S Sale | 2012-08-16 | 2012-08-17 | 53,000 | $47.57 | $2.52M | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2012-08-09 | 2012-08-13 | 70,000 | — | $0 | 70,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2012-08-09 | 2012-08-13 | 35,000 | — | $0 | 95,782 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | J Other | 2012-05-31 | 2012-06-04 | 2,581 | $6.43 | $16.6K | 60,782 | SEC↗ |
| HALO HALOZYME THERAPEUTICS INC | A Award | 2012-05-03 | 2012-05-04 | 20,000 | — | $0 | 110,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer deriv | 2012-01-18 | 2012-01-18 | 3,750 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer deriv | 2012-01-18 | 2012-01-18 | 54,420 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2012-01-18 | 2012-01-18 | 54,420 | — | $0 | 54,420 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award deriv | 2012-01-18 | 2012-01-18 | 3,750 | — | $0 | 3,750 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer | 2012-01-18 | 2012-01-18 | 53,000 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | D To issuer | 2012-01-18 | 2012-01-18 | 58,201 | — | $0 | 0 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2012-01-18 | 2012-01-18 | 53,000 | — | $0 | 53,000 | SEC↗ |
| JAZZ Jazz Pharmaceuticals plc | A Award | 2012-01-18 | 2012-01-18 | 58,201 | — | $0 | 58,201 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise deriv | 2012-01-11 | 2012-01-13 | 45,580 | — | $0 | 54,420 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise deriv | 2012-01-11 | 2012-01-13 | 40,000 | — | $0 | 0 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise deriv | 2012-01-11 | 2012-01-13 | 56,250 | — | $0 | 3,750 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | F Tax w/h | 2012-01-11 | 2012-01-13 | 29,081 | $48.60 | $1.41M | 58,201 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise | 2012-01-11 | 2012-01-13 | 45,580 | $7.35 | $335.0K | 49,008 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | F Tax w/h | 2012-01-11 | 2012-01-13 | 33,342 | $48.60 | $1.62M | 47,282 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise | 2012-01-11 | 2012-01-13 | 56,250 | $11.48 | $645.8K | 80,624 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | F Tax w/h | 2012-01-11 | 2012-01-13 | 24,634 | $48.60 | $1.20M | 24,374 | SEC↗ |
| JAZZ JAZZ PHARMACEUTICALS INC | M Exercise | 2012-01-11 | 2012-01-13 | 40,000 | $27.46 | $1.10M | 87,282 | SEC↗ |